- Home
- XBIT vs CODA Comparison
XBIT vs CODA Comparison
Compare XBIT & CODA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- XBIT
- CODA
- Stock Information
- Founded
- XBIT 2005
- CODA 1994
- Country
- XBIT United States
- CODA United States
- Employees
- XBIT N/A
- CODA N/A
- Industry
- XBIT Pharmaceuticals and Biotechnology
- CODA Industrial Machinery/Components
- Sector
- XBIT Health Care
- CODA Industrials
- Exchange
- XBIT Nasdaq
- CODA Nasdaq
- Market Cap
- XBIT 93.0M
- CODA 88.7M
- IPO Year
- XBIT 2015
- CODA N/A
- Fundamental
- Price
- XBIT $2.89
- CODA $8.25
- Analyst Decision
- XBIT
- CODA Strong Buy
- Analyst Count
- XBIT 0
- CODA 1
- Target Price
- XBIT N/A
- CODA $11.00
- AVG Volume (30 Days)
- XBIT 185.9K
- CODA 59.7K
- Earning Date
- XBIT 08-11-2025
- CODA 06-16-2025
- Dividend Yield
- XBIT N/A
- CODA N/A
- EPS Growth
- XBIT N/A
- CODA 21.86
- EPS
- XBIT N/A
- CODA 0.30
- Revenue
- XBIT N/A
- CODA $22,758,966.00
- Revenue This Year
- XBIT N/A
- CODA $30.82
- Revenue Next Year
- XBIT N/A
- CODA $20.84
- P/E Ratio
- XBIT N/A
- CODA $27.29
- Revenue Growth
- XBIT N/A
- CODA 24.78
- 52 Week Low
- XBIT $2.50
- CODA $5.76
- 52 Week High
- XBIT $8.32
- CODA $9.89
- Technical
- Relative Strength Index (RSI)
- XBIT 49.19
- CODA 57.37
- Support Level
- XBIT $2.95
- CODA $7.81
- Resistance Level
- XBIT $3.32
- CODA $8.50
- Average True Range (ATR)
- XBIT 0.17
- CODA 0.41
- MACD
- XBIT 0.00
- CODA -0.01
- Stochastic Oscillator
- XBIT 41.89
- CODA 63.45
About XBIT XBiotech Inc.
XBiotech Inc is a United States-based clinical-stage biopharmaceutical company. The company is engaged in discovering and developing True Human (antibody technology) monoclonal antibodies for treating a variety of diseases. The company focuses on developing Anti-inflammatory therapeutic antibodies as a treatment for cancer. Geographically, all of its operations are in the United States.
About CODA Coda Octopus Group Inc. Common stock
Coda Octopus Group Inc develops underwater technologies and equipment for imaging, mapping defense, and survey applications. The company's operations are organized into two reportable segments: the Products Segment (Marine Technology Business serving the subsea market and PAL, which sells other products (acoustic hydrophones and acoustic materials to a different market); and the Services Segment (Marine Engineering Business). Its geographical segments are the Americas, Europe, Australia/Asia, and the Middle East/Africa. The majority of revenue is derived from the Products segment.